Allergan Aesthetics has secured FDA approval for Skinvive by Juvéderm for the improvement of neck appearance, specifically addressing neck lines and wrinkles. The approval marks the first and only FDA-cleared injectable hyaluronic acid filler indicated for this anatomical region.
Neck and décolletage treatments represent a natural adjacency for practices already performing facial rejuvenation. Skinvive is a smooth, cohesive gel formulation designed for superficial placement, distinct from volumizing fillers like Juvéderm Ultra or Voluma. The indication opens a new revenue stream in a zone where patients increasingly seek treatment but where options have historically been limited to lasers, RF microneedling, or off-label filler use.